6Jones TC. Recombinant human GM-CSF: present clinical results and potential use in oncologic and hematologic disorders+ Bull Cancer, 1991, 78 ( 12): 1155-1159.
7Hubel K, Dale DC, Liles WC. Therapeutic use eytokines to modulate phagocyte function for the treatment of infectious diseases current status of granulocyte colony-stimulating factor, and interferongamma. J Infect Dis, 2002, 185( 10):1490-1501.
8Gulcelik MA, Dinc S, Dinc M, et al. Local granulocyte-macrophage colony-stimulating factor improve incisionl wound healing in adriamycin-treated rats. Sury Today, 2006, 36( 1 ): 47-51.
9Hocher B, Schwarz A, Fagan KA, et al. Pulmonnary fibrosis and chronic lung inflammation in ET-1 transgenic mice. Am J Respir Cell Mo Biol, 2000, 23 (1): 19-26.
10Jaschke E, Zabernigg A, Gattringer C. Recombinant human granulocyte-macrophage colony-stimulating factor applied locally in low doses enhances healing and prevents recurrence of chronic renous ulcers. Int J Dennatol, 1999, 38 (5): 380-386.
